Predictors of recurrence during long-term treatment of bipolar I and II disorders. A 4 year prospective naturalistic study

Journal of Affective Disorders

Volumn 225, Issue , 2018, Pages 123-128

  Tundo, Antonio ^a   Musetti, Laura ^b   Benedetti, Alessandra ^b   Massimetti, Enrico ^c   Pergentini, Irene ^b   Cambiali, Erika ^b   Dell'Osso, Liliana ^b  

^a Istituto di Psicopatologia   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Bergamo ovest   (Italy)

Author keywords

Bipolar disorder I; Bipolar disorder II; Mixed states; Predictors; Recurrences; Relapse

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VALPROIC ACID; ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIXED MANIA AND DEPRESSION; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; BIPOLAR DISORDER; DISEASE EXACERBATION; MIDDLE AGED; PROCEDURES; PROGNOSIS; PSYCHOLOGY; REPRODUCIBILITY; SECONDARY HEALTH CARE;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; REPRODUCIBILITY OF RESULTS; SECONDARY CARE;

EID: 85027564677     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.08.013     Document Type: Article

References (53)

1. Altman, S., Haeri, S., Cohen, L.J., Ten, A., Barron, E., Galynker, I.I., Duhamel, K.N., Predictors of relapse in bipolar disorder: a review. J. Psychiatr. Pract. 12 (2006), 269–282.
2. American Psychiatric Association (APA), Diagnostic and Statistical Manual of Mental Disorders. 4th ed., 1994, American Psychiatric Association, Washington, DC.
3. American Psychiatric Association (APA), Practice guidelines for the treatment of patients with bipolar disorder. Am. J. Psychiatry 141 (2002), 1–36.
4. American Psychiatric Association (APA), Diagnostic and Statistical Manual of Mental Disorders fifth edition (DSM-5). 2013, American Psychiatric Association, Washington, DC.
5. Amit, B.H., Weizman, A., Antidepressant treatment for acute bipolar depression: an update. Depress Res. Treat. 2012 (2012), 1–10.
6. Benazzi, F., Koukopoulos, A., Akiskal, H.S., Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur. Psychiatry 19 (2004), 85–90.
7. Berk, M., Dodd, S., Berk, L., The management of bipolar disorder in primary care: a review of existing and emerging therapies. Psychiatry Clin. Neurosci. 59 (2005), 229–239.
8. Bromet, E.J., Finch, S.J., Carlson, G.A., Fochtmann, L., Mojtabai, R., Craig, T.J., Kang, S., Ye, Q., Time to remission and relapse after the first hospital admission in severe bipolar disorder. Soc. Psychiatry Psychiatr. Epidemiol. 40 (2005), 106–113.
9. Cassano, G.B., Musetti, L., Perugi, G., Soriani, A., Mignani, V., McNair, D.M., Akiskal, H.S., A proposed new approach to the clinical subclassification of depressive illness. Pharmacopsychiatry 21 (1988), 19–23.
10. Cretu, J.B., Culver, J.L., Goffin, K.C., Shah, S., Ketter, T.A., Sleep, residual mood symptoms, and time to relapse in recovered patients with bipolar disorder. J. Affect. Disord. 190 (2016), 162–166.
11. De Dios, C., Ezquiaga, E., Agud, J.L., Vieta, E., Soler, B., García-López, A., Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients. J. Affect. Disord. 143 (2012), 160–165.
12. Dell'Osso, L., Pini, S., Tundo, A., Sarno, N., Musetti, L., Cassano, G.B., Clinical characteristics of mania, mixed mania, and bipolar depression with psychotic features. Compr. Psychiatry 41 (2000), 242–247.
13. El-Mallakh, R.S., Vöhringer, P.A., Ostacher, M.M., Baldassano, C.F., Holtzman, N.S., Whitham, E.A., Thommi, S.B., Goodwin, F.K., Ghaemi, S.N., Antidepressants worsen rapid-cycling course in bipolar depression: a STEP-BD randomized clinical trial. J. Affect. Disord. 184 (2015), 318–321.
14. Fagiolini, A., Frank, E., Axelon, D.A., Birmaher, B., Cheng, Y., Curet, D.E., Fridman, E.S., Gildenger, A.G., Goldstein, T., Grochocinski, V.J., Houck, P.R., Stofko, M.G., Thasew, M.E., Thompson, W.K., Turkin, S.R., Kupfer, D.J., Enhancing outcomes in patients with bipolar disorder: results from the Bipolar Disorder Center for Pennsylvanian study. Bip. Disord. 11 (2009), 382–390.
15. Fagiolini, A., Forgione, R., Maccari, M., Cuomo, A., Morana, B., Dell'Osso, M.C., Pellegrini, F., Rossi, A., Prevalence, chronicity, burden and borders of bipolar disorder. J. Affect. Disord. 148 (2013), 161–169.
16. Fekadu, A., Kebede, D., Alem, A., Fekadu, D., Mogga, S., Negash, A., Medhin, G., Beyero, T., Shibre, T., Clinical outcome in bipolar disorder in a community-based follow-up study in Butajira, Ethiopia. Acta Psychiatr. Scand. 114 (2006), 426–434.
17. First, M.B., Donovan, S., Frances, A., Nosology of chronic mood disorders. Psychiatr. Clin. North Am. 19 (1996), 29–39.
18. First, M.B., Gibbon, M., Spitzer, R.L., Benjamin, L.S., User's Guide for the Structured Clinical Interview for DSM-IV Axis II Personality Disorders: SCID-II. 1997, American Psychiatric Pub.
19. Fountoulakis, K.N., Kasper, S., Andreassen, O., Blier, P., Okasha, A., Severus, E., Versiani, M., Tandon, R., Möller, H.J., Vieta, E., Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. Eur. Arch. Psychiatry Clin. Neurosci. 262 (2012), 1–48.
20. Ghaemi, S.N., Hsu, D.J., Soldani, F., Goodwin, F.K., Antidepressants in bipolar disorder: the case for caution. Bipolar Disord. 5 (2003), 421–433.
21. González-Pinto, A., Aldama, A., González, C., Mosquera, F., Arrasate, M., Vieta, E., Predictors of suicide in first-episode affective and nonaffective psychotic inpatients: five-year follow-up of patients from a catchment area in Vitoria, Spain. J. Clin. Psychiatry 68 (2007), 242–247.
22. González-Pinto, A., Barbeito, S., Alonso, M., Alberich, S., Haidar, M.K., Vieta, E., Tabarés-Seisdedos, R., Zorrilla, I., González-Pinto, M.A., López, P., Poor long-term prognosis in mixed bipolar patients: 10-year outcomes in the vitoria prospective naturalistic study in Spain. J. Clin. Psychiatry 72 (2011), 671–676.
23. Goodwin, F.K., Jamison, K.R., Manic-depressive Illness: Bipolar Disorders and Recurrent Depression. 2007, Oxford University Press, New York.
24. Goodwin, G., Haddad, P., Ferrier, I., Aronson, J., Barnes, T., Cipriani, A., Coghill, D., Fazel, S., Geddes, J., Grunze, H., Holmes, E., Howes, O., Hudson, S., Hunt, N., Jones, I., Macmillan, I., McAllister-Williams, H., Miklowitz, D., Morriss, R., Munafo, M., Paton, C., Saharkian, B., Saunders, K., Sinclair, J., Taylor, D., Vieta, E., Young, A., Evidence-based guidelines for treating bipolar disorder: Revisedthird edition recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. 30 (2016), 495–553.
25. Judd, L.L., Akiskal, H.S., Schettler, P.J., Coryell, W., Endicott, J., Maser, J.D., Solomon, D.A., Leon, A.C., Keller, M.B., A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch. Gen. Psychiatry 60 (2003), 261–269.
26. Keller, M.B., Lavori, P.W., Friedman, B., Nielsen, E., Endicott, J., McDonald-Scott, P., Andreasen, N.C., The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies. Arch. Gen. Psychiatry 44 (1987), 540–548.
27. Keller, M.B., Lavori, P.W., Kane, J.M., Gelenberg, A.J., Rosenbaum, J.F., Walzer, E.A., Baker, L.A., Subsyndromal symptoms in bipolar disorder. A comparison of standard and low serum levels of lithium. Arch. Gen. Psychiatry 49 (1992), 371–376.
28. Kessing, L.V., Hansen, M.G., Andersen, P.K., Angst, J., The predictive effect of episodes on the risk of recurrence in depressive and bipolar disorders–a life-long perspective. Acta Psychiatr. Scand. 109 (2004), 339–344.
29. Kora, K., Saylan, M., Akkaya, C., Karamustafalioglu, N., Tomruk, N., Yasan, A., Oral, T., Predictive factors for time to remission and recurrence in patients treated for acute mania: Health Outcomes of Manic Episodes (HOME) study. Prim. Care Companion J. Clin. Psychiatry 10 (2008), 114–119.
30. Koukopoulos, A., Koukopoulos, A., Agitated depression as a mixed state and the problem of melancholia. Psychiatr. Clin. North Am. 22 (1999), 547–564.
31. Koukopoulos, A., Sani, G., DSM-5 criteria for depression with mixed features: a farewell to mixed depression. Acta Psychiatr. Scand. 129 (2014), 4–16.
32. Li, C., Chen, C., Qiu, B., Yang, G., A 2-year follow-up study of discharged psychiatric patients with bipolar disorder. Psychiatry Res. 218 (2014), 75–78.
33. Miklowitz, D.J., Scott, J., Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions. Bipolar Disord. 11 (2009), 110–122.
34. Miller, S., Suppes, T., Mintz, J., Hellemann, G., Frye, M.A., McElroy, S.L., Nolen, W.A., Kupka, R., Leverich, G.S., Grunze, H., Altshuler, L.L., Keck, P.E., Post, R.M., Mixed depression in bipolar disorder: prevalence rate and clinical correlates during naturalistic follow-up in the stanley bipolar network. Am. J. Psychiatry 173 (2016), 1015–1023.
35. Montgomery, S.A., Schatzberg, A.F., Guelfi, J.D., Kasper, S., Nemeroff, C., Swann, A., Zajecka, J., Pharmacotherapy of depression and mixed states in bipolar disorder. J. Affect. Disord. 59 (2000), 39–56.
36. Montoya, A., Tohen, M., Vieta, E., Casillas, M., Chacón, F., Polavieja, P., Gilaberte, I., Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort study. J. Affect. Disord. 127 (2010), 50–57.
37. Pacchiarotti, I., Bond, D.J., Baldessarini, R.J., Nolen, W.A., Grunze, H., Licht, R.W., Post, R.M., Berk, M., Goodwin, G.M., Sachs, G.S., Tondo, L., Findling, R.L., Youngstrom, E.A., Tohen, M., Undurraga, J., González-Pinto, A., Goldberg, J.F., Yildiz, A., Altshuler, L.L., Calabrese, J.R., Mitchell, P.B., Thase, M.E., Koukopoulos, A., Colom, F., Frye, M.A., Malhi, G.S., Fountoulakis, K.N., Vázquez, G., Perlis, R.H., Ketter, T.A., Cassidy, F., Akiskal, H., Azorin, J.-M., Valentí, M., Mazzei, D.H., Lafer, B., Kato, T., Mazzarini, L., Martínez-Aran, A., Parker, G., Souery, D., Özerdem, A., McElroy, S.L., Girardi, P., Bauer, M., Yatham, L.N., Zarate, C.A., Nierenberg, A.A., Birmaher, B., Kanba, S., El-Mallakh, R.S., Serretti, A., Rihmer, Z., Young, A.H., Kotzalidis, G.D., MacQueen, G.M., Bowden, C.L., Ghaemi, S.N., Lopez-Jaramillo, C., Rybakowski, J., Ha, K., Perugi, G., Kasper, S., Amsterdam, J.D., Hirschfeld, R.M., Kapczinski, F., Vieta, E., The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am. J. Psychiatry 170 (2013), 1249–1262.
38. Pallaskorpi, S., Suominen, K., Ketokivi, M., Mantere, O., Arvilommi, P., Valtonen, H., Leppämäki, S., Isometsä, E., Five-year outcome of bipolar I and II disorders: findings of the Jorvi bipolar study. Bipolar Disord. 17 (2015), 363–374.
39. Perlis, R.H., Ostacher, M.J., Patel, J.K., Marangell, L.B., Zhang, H., Wisniewski, S.R., Ketter, T.A., Miklowitz, D.J., Otto, M.W., Gyulai, L., Reilly-Harrington, N.A., Nierenberg, A.A., Sachs, G.S., Thase, M.E., Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am. J. Psychiatry 163 (2006), 217–224.
40. Peselow, E.D., Clevenger, S., IsHak, W.W., Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder. Int. Clin. Psychopharmacol. 31 (2016), 218–223.
41. Sani, G., Vöhringer, P.A., Napoletano, F., Holtzman, N.S., Dalley, S., Girardi, P., Nassir Ghaemi, S., Koukopoulos, A., Koukopoulos' diagnostic criteria for mixed depression: a validation study. J. Affect. Disord. 164 (2014), 14–18.
42. Simhandl, C., König, B., Amann, B.L., A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J. Clin. Psychiatry 75 (2014), 254–262.
43. Solomon, D.A., Keitner, G.I., Miller, I.W., Shea, M.T., Keller, M.B., Course of illness and maintenance treatments for patients with bipolar disorder. J. Clin. Psychiatry 56 (1995), 5–13.
44. Sportiche, S., Geoffroy, P.A., Brichant-Petitjean, C., Gard, S., Khan, J.-P., Azorin, J.-M., Henry, C., Leboyer, M., Etain, B., Scott, J., Bellivier, F., Clinical factors associated with lithium response in bipolar disorders. Aust. N. Z. J. Psychiatry 51 (2017), 524–530.
45. Swann, A.C., Lafer, B., Perugi, G., Frye, M.A., Bauer, M., Bahk, W.M., Scott, J., Ha, K., Suppes, T., Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am. J. Psychiatry 170 (2013), 31–42.
46. Takeshima, M., Oka, T., DSM-5-defined “mixed features” and Benazzi's mixed depression: which is practically useful to discriminate bipolar disorder from unipolar depression in patients with depression?. Psychiatry Clin. Neurosci. 69 (2015), 109–116.
47. Tohen, M., Waternaux, C.M., Tsuang, M.T., Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch. Gen. Psychiatry 47 (1990), 1106–1111.
48. Tohen, M., Zarate, C.A., Hennen, J., Khalsa, H.-M.K., Strakowski, S.M., Gebre-Medhin, P., Salvatore, P., Baldessarini, R.J., The McLean-Harvard first-episode mania study: prediction of recovery and first recurrence. Am. J. Psychiatry 160 (2003), 2099–2107.
49. Tohen, M., Frank, E., Bowden, C.L., Colom, F., Ghaemi, S.N., Yatham, L.N., Malhi, G.S., Calabrese, J.R., Nolen, W.A., Vieta, E., Kapczinski, F., Goodwin, G.M., Suppes, T., Sachs, G.S., Chengappa, K.R., Grunze, H., Mitchell, P.B., Kanba, S., Berk, M., The International Society for Bipolar Disorders (ISBD) task force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord. 11 (2009), 453–473.
50. Tundo, A., Cavalieri, P., Navari, S., Marchetti, F., Treating bipolar depression–antidepressants and alternatives: a critical review of the literature. Acta Neuropsychiatr. 23 (2011), 94–105.
51. Tundo, A., Musetti, L., Benedetti, A., Berti, B., Massimetti, G., Dell'Osso, L., Onset polarity and illness course in bipolar I and II disorders: the predictive role of broadly defined mixed states. Compr. Psychiatry 63 (2015), 15–21.
52. Vázquez, G.H., Tondo, L., Undurraga, J., Baldessarini, R.J., Overview of antidepressant treatment of bipolar depression. Int. J. Neuropsychopharmacol. 16 (2013), 1673–1685.
53. Vieta, E., The treatment of mixed states and the risk of switching to depression. Eur. Psychiatry 20 (2005), 96–100.